The US government’s top physician and immunologist Dr. Anthony Stephen Fauci says. He is optimistic about the positive preliminary Positive results found after the trial run of the experimental treatment of coronavirus with Remdesivir drug.
Fauci’s activities led to the discovery of antiviral drugs for HIV. That Fauci claims that in the United States, remediation is acting as a shield on the body of COVID-19 remdesivir drug trial positive. The antiviral drug has been administered to more than 1,690 people in the United States, according to said him. Observations revealed that Compared to common medicine Patients who were treated with Remdesivir drugs took less than 30 percent of the time to recover. Previously applied medications took 15 days to prevent coronavirus and after applying for Remdesivir drugs, it takes 4 days to recover.
|In The White House press briefing Dr. Anthony Stephen Fauci (left) says about coronavirus recharge proggers in media. On the right side stand President Donald Trump|
An American pharmaceutical company called Gilead has issued a statement regarding the drug Remdesivir they produce. The statement said “positive data” was found after a trial run by the National Institute of Allergy and Infectious Diseases (NIAID) in the United States, and that the test “achieved their initial goal.”
The Gilead pharmaceutical company reports that Remdesivir medicine has been worked to prevent from Covid-19. it is an antiviral medication that was created to treat Ebola. However, the company indicates that the earlier the Remdesivir is given, the more effective it is. Gilead states, “It has been possible to release 62 percent of the patients who have been dealt with already. And 49 percent of the patients who were given late has left the hospital.
Gilead’s share price rose more than 6 percent on Wednesday after US President Trump praised the drug as “positive.” Anthony Fauci, a doctor with the U.S. Coronavirus Task Force, said the initial results were very promising. However, scientists in many countries have disagreed on the effectiveness and success of this drug.
Prior to the announcement, the science magazine The Lancet quoted a test by Remedisevir in China as saying that this drug did not work – but the survey was not completed because there were not enough patients at the time.
|Gilead pharmaceutical companies deadly COVID-19 research team members|